Pfizer's inhalable insulin a first for diabetics | Packaging World
Breaking Down Barriers: A Second Attempt at Inhaled Insulin - Steven Sparkes, Jennifer Goldman-Levine, 2015
Inhaled Insulin: Into Thin Air?
Weak Sales Prompt Pfizer to Cancel Diabetes Drug - The New York Times
Exubera inhaler system | Download Scientific Diagram
Look Ma! No Bong! Afrezza Inhaled Insulin Device is a Cool Gadget - Pharma Marketing Network
Exubera inhaler system. (Courtesy of Pfizer.) | Download Scientific Diagram
Left and center: Exubera inhaled insulin delivery system. (Courtesy of... | Download Scientific Diagram
FDA approves inhaled insulin for diabetes
Inhaled Insulin: Exubera | Semantic Scholar
Is Inhaled Insulin A Viable Alternative For Patients With Diabetes?
Exubera – Virtual tour of Museum of Failure
Drugmakers launch inhaled insulin for needle-phobic diabetics | CTV News
NGSM IPS Reunion - FDA Finally OKs Inhaled Insulin After several denials, the FDA announced Friday that it had approved inhaled insulin (Afrezza) to be used for improving glycemic control in adult
Exubera' insulin inhaler, United States, 2002-2007 | Science Museum Group Collection
MedTech Memoirs: Inhalable Insulin Flops...Twice - Medical Design and Outsourcing
Sugarcoating-Insulin-Failures
Exubera Insulin Delivery System Kit 1 mg and 3 mg Inhalation Powder Blisters 270 Blisters - Suprememed
Inhaled Insulin: A Breath of Fresh Air? A Review of Inhaled Insulin - ScienceDirect
L'insuline en blister affiché à côté d'un dispositif d'inhalation, qui est offert par la société pharmaceutique Pfizer sous le nom de "Exubera', à Francfort-sur-Main, Allemagne, lundi 20 novembre 2006. Le médicament est
Insulin Flop Costs Pfizer $2.8 Billion - WSJ
Exubera inhaled insulin: a review - Barnett - 2004 - International Journal of Clinical Practice - Wiley Online Library
Inhaled Insulin for Diabetes Mellitus | NEJM
Afrezza (Insulin Human) Inhalation Powder: A New Inhaled Insulin for the Management Of Type-1 or Type-2 Diabetes Mellitus. - Abstract - Europe PMC
Exubera at best price in by Get Well Pharma. Ltd. | ID: 9320631088
Future prospect of insulin inhalation for diabetic patients: The case of Afrezza versus Exubera - ScienceDirect
Inhaled insulin: a clinical perspective with emphasis on EXUBERA